Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07152873 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 4, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: Oct 20, 2025 to Dec 1, 2025
    • Primary completion date: Nov 2025 to Feb 2026
    • Study completion date: Dec 2025 to Mar 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-117 in healthy subjects.
Trial Details
NCT Number NCT07152873
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Mixed Dyslipidemia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov